指南与共识血栓与止血

ISTH血浆凝血抑制物小组委员会:蛋白C缺乏症临床实验室检测建议

Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH.
指南 / 共识 · J Thromb Haemost · 2020-01-01

该指南由ISTH血浆凝血抑制物小组委员会制定,针对遗传性和获得性蛋白C缺乏的实验室检测提出建议。推荐使用显色法作为首选,因其特异性好,但需注意其无法检测罕见的2b型缺乏;凝血法可检测2b型但特异性较低。同时强调年龄对参考范围的影响及分析前变量和直接口服抗凝药对检测的干扰。

要点

  • 显色法检测蛋白C特异性好,推荐为首选方法。
  • 凝血法可检测2b型蛋白C缺乏,但特异性较低。
  • 儿童蛋白C水平随年龄变化,不能直接采用成人参考范围。

核心结论

  • 推荐使用显色法检测蛋白C缺乏,因其特异性好;凝血法可检测2b型但特异性较低。
  • 蛋白C水平随年龄变化,儿童不能使用成人参考范围。

研究设计与样本

  • 由ISTH血浆凝血抑制物小组委员会制定的临床实验室检测建议。

主要发现

  • 遗传性蛋白C缺乏在易栓家族中增加静脉血栓栓塞风险5至10倍,但杂合性缺乏 alone 不决定血栓倾向。
  • 纯合或复合杂合蛋白C缺乏罕见且严重,患儿家族常无蛋白C缺乏或血栓史。
  • 显色法无法检测罕见的2b型蛋白C缺乏,该型缺陷源于与钙离子、磷脂、蛋白S、因子Va和VIIIa相互作用不良。
  • 凝血法可检测2b型蛋白C缺乏,但特异性降低。
  • 部分凝集的样本用显色法会假性升高蛋白C水平,而凝血法会降低水平。

关键数值与推荐

  • 显色法推荐用于诊断蛋白C缺乏,因其特异性好。
  • 凝血法能够检测2b型蛋白C缺乏,但特异性较低。
  • 成人参考范围不能应用于婴儿或儿童,蛋白C水平可能至青春期仍未达成人水平。

临床怎么用

  • 实验室应首选显色法检测蛋白C缺乏,但需知晓其无法检测2b型。
  • 对儿童评估蛋白C时需使用年龄特异性参考范围。
  • 注意分析前变量如样本部分凝集对检测结果的影响,且影响因检测方法而异。
  • 使用直接口服抗凝药的患者,凝血法测蛋白C会假性升高,应选用显色法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inherited protein C (PC) deficiency increases risk of venous thromboembolism (VTE) by 5 to 10-fold in thrombosis-prone families; however, heterozygous PC deficiency alone does not determine that a subject has thrombophilia. Protein C deficient subjects, who lack additional inherited risk factors such as factor V Leiden or have no major acquired risk factors, may not suffer from VTE. In addition, PC deficiency may be acquired, often due to vitamin K antagonist treatment or liver disease. In contrast, homozygous or compound heterozygous PC deficiencies are rare and serious disorders, and affected infants are often in families with no history of PC deficiency or thrombosis. Laboratories commonly use the chromogenic PC assay to diagnose deficiency. Chromogenic assay is recommended due to its good specificity, but this assay fails to detect the rare type 2b deficiency where the defect is due to poor interaction with calcium ions, phospholipid, protein S, and factor Va and factor VIIIa. The clotting-based assay of PC is capable of detecting type 2b deficiency but it has reduced specificity. Importantly, PC level varies with age, adult reference ranges cannot be applied to babies or children and levels may not reach those of adults even in adolescence. Pre-analytical variables in the specimen affect measurement of PC, and can be assay-dependent; for example, a partially clotted sample will have falsely raised PC level by chromogenic assay but reduced level by clotting-based assay. Direct oral anticoagulants falsely raise PC level in the clotting-based assay but the standard chromogenic assay is unaffected.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Cooper PC, Pavlova A, Moore GW, et al. Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH. J Thromb Haemost. 2020. PMID: 31999059. doi:10.1111/jth.14667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。